SolasCure wins 1st place at prestigious EIT Health Catapult biotech competition for investigational wound care product Aurase Wound Gel

SolasCure has been named the winner of the biotech category at the EIT Health Catapult finals in Stockholm. The medical use of Aurase Wound Gel is being developed with the…

Continue ReadingSolasCure wins 1st place at prestigious EIT Health Catapult biotech competition for investigational wound care product Aurase Wound Gel
Read more about the article Cambridge biotech company earns international recognition as first trial patient receives treatment
Back View of Team of Senior and Young Scientists Working on Problem Solution. They're Looking for Information on a Computer. Their Laboratory is Ulta Modern.

Cambridge biotech company earns international recognition as first trial patient receives treatment

SolasCure, a Cambridge-based biotech company developing revolutionary wound-cleaning technology, has seen its first trial patient receive treatment. Leveraging biomimicry and evidence-based medicine, the pioneering biologics company is developing its first…

Continue ReadingCambridge biotech company earns international recognition as first trial patient receives treatment

Biotech start-up SolasCure has begun clinical trials of its investigational wound cleaning product, Aurase Wound Gel

Cambridge-based biologics company SolasCure has received authorisation to conduct clinical trials for its investigational product, Aurase Wound Gel, from the UK’s Medical and Healthcare products Regulatory Agency (MHRA) and approval…

Continue ReadingBiotech start-up SolasCure has begun clinical trials of its investigational wound cleaning product, Aurase Wound Gel